Vyne Therapeutics

Late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus.

HQ location

Menlo Park, United States

Website

vynetherapeutics.com

Launch date

2011

Employees

Market cap

Enterprise value

($31m)

Share price

$0.33 VYNE

https://twitter.com/vynetx https://www.linkedin.com/company/menlo-therapeutics-inc

Authorizing premium user...